Popular diabetes and weight-loss drug may reduce risk of Alzheimer's disease

MCG neuroscientist receives $2.3 million in funding from NIH High-Risk, High-Reward Research program - EurekAlert

Popular diabetes and weight-loss drug may reduce risk of Alzheimer’s disease - EurekAlert

Active ingredient in Ozempic, Wegovy may reduce risk of Alzheimer's disease: Study